• 2397 Citations
  • 24 h-Index
20102020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Francois MULLIER is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 18 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Research Output

Assessment of low plasma concentrations of apixaban in the periprocedural setting

Lessire, S., Dincq, A-S., Siriez, R., Pochet, L., Sennesael, A-L., Vornicu, O., Hardy, M., Deceuninck, O., Douxfils, J. & Mullier, F., 16 Apr 2020, In : International Journal of Laboratory Hematology.

Research output: Contribution to journalArticle

  • File
  • Andexanet alfa for the reversal of factor Xa inhibitors

    Favresse, J., Hardy, M., van Dievoet, M. A., Sennesael, A. L., Douxfils, J., Samama, C. M., Vornicu, O., Dincq, A. S., Lessire, S. & Mullier, F., 4 May 2019, In : Expert Opinion on Biological Therapy. 19, 5, p. 387-397 11 p.

    Research output: Contribution to journalArticle

  • Assessment of the analytical performances and sample stability on ST Genesia system using the STG-DrugScreen application

    Douxfils, J., Morimont, L., Bouvy, C., de Saint-Hubert, M., Devalet, B., Devroye, C., Dincq, A-S., Dogné, J-M., Guldenpfennig, M., Baudar, J., Larock, A-S., Lessire, S. & Mullier, F., Aug 2019, In : Journal of thrombosis and haemostasis : JTH. 17, 8, p. 1273-1287 15 p.

    Research output: Contribution to journalArticle

  • Prizes

    Prix Léo Pharma Cancer & Thrombosis

    Haguet, Helene (Recipient), DOUXFILS, JONATHAN (Recipient), MULLIER, Francois (Recipient) & DOGNE, Jean-Michel (Recipient), 25 Feb 2017

    Prize: Prize (including medals and awards)

    Activities

    • 6 Oral presentation

    Mécanismes thrombotiques des inhibiteurs de tyrosine kinase ciblant BCR-ABL

    Hélène Haguet (Speaker), , Jonathan Douxfils (Speaker), , François Mullier (Speaker), , Christian Chatelain (Speaker), , Carlos Graux (Speaker), & Jean-Michel Dogne (Speaker)

    21 Mar 2019

    Activity: Talk or presentation typesOral presentation

    In vitro effects of BCR-ABL TKIs on endothelial cell survival and functions

    Hélène Haguet (Speaker), , Jonathan Douxfils (Speaker), , Christian Chatelain (Speaker), , Carlos Graux (Speaker), , François Mullier (Speaker), & Jean-Michel Dogne (Speaker)

    9 Feb 2018

    Activity: Talk or presentation typesOral presentation

    Risk of vascular occlusive events with BCR-ABL TKIs in CML

    Hélène Haguet (Speaker), , Jonathan Douxfils (Speaker), , François Mullier (Speaker), , Christian Chatelain (Speaker), , Carlos Graux (Speaker), & Jean-Michel Dogne (Speaker)

    25 Feb 2017

    Activity: Talk or presentation typesOral presentation

    Risk of vascular occlusive events with BCR-ABL TKIs in CML - A systematic review and meta-analysis

    Hélène Haguet (Speaker), , Jonathan Douxfils (Speaker), , François Mullier (Speaker), , Christian Chatelain (Speaker), , Carlos Graux (Speaker), & Jean-Michel Dogne (Speaker)

    28 Apr 2016

    Activity: Talk or presentation typesOral presentation

    Risk of vascular occlusive events with BCR-ABL TKIs in CML - A systematic review and meta-analysis

    Hélène Haguet (Speaker), , Jonathan Douxfils (Speaker), , François Mullier (Speaker), , Christian Chatelain (Speaker), , Carlos Graux (Speaker), & Jean-Michel Dogne (Speaker)

    29 Jan 2016

    Activity: Talk or presentation typesOral presentation

    Thesis

    Evaluation of thrombotic and/or bleeding risks associated with anticoagulotherapy.

    Author: Douxfils, J., 24 Oct 2015

    Supervisor: Dogne, J. (Supervisor), Mullier, F. (Supervisor), Masereel, B. (President), Chatelain, B. (Jury), Chatelain, C. (External person) (Jury), Verhamme, P. (External person) (Jury), TEN CATE, H. (External person) (Jury) & Ageno, W. (External person) (Jury)

    Student thesis: Doc typesDoctor of Biomedical and Pharmaceutical Sciences

    La souris déficiente en hyaluronidase de Type2 (HYAL2) : modèle murin d'une anémie hémolytique suite à une nouvelle forme de microangiopathie thrombotique

    Author: Onclinx, C., 2 Oct 2015

    Supervisor: Flamion, B. (Supervisor), Boonen, M. (Jury), Caron, N. (Jury), Mullier, F. (Jury), Poumay, Y. (Jury), Beguin, Y. (External person) (Jury) & Chatelain, C. (External person) (Jury)

    Student thesis: Doc typesDoctor of Biomedical and Pharmaceutical Sciences

    Quantification and characterization of microvesicles: applications in hereditary spherocytosis, type-II heparin-induced thrombocytopenia and cancer

    Author: Mullier, F., 26 Mar 2012

    Supervisor: Dogne, J. (Supervisor), Masereel, B. (President), Chatelain, B. (External person) (Co-Supervisor), Michiels, C. (Jury), Latinne, D. (External person) (Jury), Chatelain, C. (External person) (Jury), Wallemacq, P. (External person) (Jury), Harrison, P. (External person) (Jury) & Hoylaerts, M. F. (External person) (Jury)

    Student thesis: Doc typesDoctor of Biomedical and Pharmaceutical Sciences

    Study of the potential role of extracellular vesicles in thrombosis associated with paroxysmal nocturnal hemoglobinuria and red blood cell concentrates transfusions

    Author: Wannez, A., 12 Sep 2018

    Supervisor: Dogne, J. (Supervisor), Mullier, F. (Supervisor), Masereel, B. (President), Brichard, S. (External person) (President), Chatelain, C. (External person) (Jury), Chatelain, B. (Jury), Van Den Neste, E. (External person) (Jury), Delettre, F. (External person) (Jury) & Gerotziafas , G. (External person) (Jury)

    Student thesis: Doc typesDoctor of Biomedical and Pharmaceutical Sciences